Related Experiment Video
Updated: Mar 9, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
Pathophysiological differences between multifocal fibromuscular dysplasia and atherosclerotic renal artery stenosis
Daan J L van Twist1, Alfons J H M Houben, Michiel W de Haan
1aDepartment of Internal Medicine bCardiovascular Research Institute Maastricht (CARIM) cDepartment of Radiology, Maastricht University Medical Center (MUMC+), Maastricht dDepartment of Internal Medicine, Zuyderland Medical Center, Sittard, The Netherlands.
Background:
Fibromuscular dysplasia (FMD) and atherosclerotic renal artery stenosis (ARAS) are the most common causes of renovascular hypertension. So far, FMD is believed to cause hypertension via similar mechanisms as in ARAS, that is, a decrease in renal blood flow, which subsequently leads to increased renin secretion. However, given the differences in the blood pressure (BP)-lowering effect of revascularization between patients with ARAS and FMD, we questioned whether this is true.
Methods:
We measured renal blood flow (Xenon washout method) and renin secretion per kidney and their relationship to BP in a cohort of 64 patients with multifocal FMD and 110 patients with ARAS (off medication, prior to revascularization).
Results:
We found that renal blood flow is significantly higher in FMD as compared with ARAS. In patients with unilateral ARAS, renin secretion was increased in the affected kidney as compared with the unaffected kidney. This lateralization in renin secretion, however, was not found in unilateral FMD. After correction for differences in baseline characteristics, we found that systemic renin levels and local renin secretion was lower in FMD as compared with ARAS. Moreover, the relationship between BP and renin secretion in FMD was inverse to that in ARAS.
Conclusion:
These findings argue against the hypothesis that FMD induces hypertension via similar pathophysiological mechanism as in ARAS.
Insights
Fibromuscular dysplasia (FMD) and atherosclerotic renal artery stenosis (ARAS) cause hypertension differently. FMD patients have higher renal blood flow and lower renin secretion compared to ARAS patients, challenging current theories.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Hypertension Research
Background:
- Fibromuscular dysplasia (FMD) and atherosclerotic renal artery stenosis (ARAS) are leading causes of renovascular hypertension.
- Current understanding suggests FMD-induced hypertension mimics ARAS mechanisms, involving reduced renal blood flow and increased renin secretion.
- Discrepancies in blood pressure response to revascularization between FMD and ARAS patients necessitate further investigation.
Purpose of the Study:
- To investigate the distinct pathophysiological mechanisms underlying hypertension in FMD versus ARAS.
- To compare renal blood flow, renin secretion, and their relationship with blood pressure in patients with FMD and ARAS.
Main Methods:
- Renal blood flow was measured using the Xenon washout method.
- Renin secretion per kidney and blood pressure were assessed in 64 patients with multifocal FMD and 110 patients with ARAS.
- Measurements were taken off medication and prior to revascularization.
Main Results:
- Renal blood flow was significantly higher in FMD patients compared to ARAS patients.
- Renin secretion lateralization to the affected kidney was observed in unilateral ARAS but not in unilateral FMD.
- Systemic renin levels and local renin secretion were lower in FMD, with an inverse relationship between blood pressure and renin secretion compared to ARAS.
Conclusions:
- The findings challenge the hypothesis that FMD causes hypertension through the same pathophysiological mechanisms as ARAS.
- Distinct mechanisms may be involved in FMD-induced hypertension, warranting different therapeutic considerations.
Related Concept Videos
Mitral Stenosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Peripheral Artery Disease I: Introduction
Rheumatic Heart Disease I: Introduction

